Items where Subject is "FOR Classification > 1115 Pharmacology and Pharmaceutical Sciences"
![]() | Up a level |
- School/Research Area (9950)
- FOR Classification (8366)
- 1115 Pharmacology and Pharmaceutical Sciences (34)
- FOR Classification (8366)
B
Berk, L, Hallam, Karen, Colom, F, Vieta, E, Hasty, Melissa, Macneil, Craig and Berk, Michael (2010) Enhancing medication adherence in patients with bipolar disorder. Human Psychopharmacology: Clinical and Experimental, 25 (1). pp. 1-16. ISSN 0885-6222
C
Cheenpracha, S, Zhang, Hao Lan, Mar, A.M, Foss, A, Foo, S, Lai, N, Jee, J, Seow, Heng-Fong, Ho, C and Chang, L (2009) Yeast Glycogen Synthase Kinase-3β Pathway Inhibitors from an Organic Extract of Streptomyces sp. Journal of Natural Products, 72 (8). pp. 1520-1523. ISSN 0163-3864
D
Dass, Crispin R and Choong, P. F. M (2008) Gene therapy for osteosarcoma: steps towards clinical studies. Journal of Pharmacy and Pharmacology, 60 (4). pp. 405-413. ISSN 0022-3573
Dass, Crispin R and Choong, Peter F. M (2007) GFP expression alters osteosarcoma cell biology. DNA Cell Biology, 26 (8). pp. 599-601. ISSN 1044-5498
Dass, Crispin R and Choong, Peter F. M (2007) Non-viral methods for gene transfer towards osteosarcoma therapy. Journal of Drug Targeting, 15 (3). pp. 184-189. ISSN 1061-186X
Dass, Crispin R, Friedhuber, A, Khachigian, L, Dunstan, D and Choong, Peter F. M (2008) Downregulation of c-jun results in apoptosis-mediated anti-osteosarcoma activity in an orthotopic model. Cancer Biology and Therapy, 7 (7). pp. 1033-1036. ISSN 1538-4047
Dass, Crispin.R and Choong, P (2008) Pigment epithelium-derived factor (PEDF): drug developmental challenges ahead for a budding anti-angiogenic. Die Pharmazie, 63 (1). pp. 4-6. ISSN 0031-7144
Dass, Crispin.R, Choong, P and Khachigian, L (2008) DNAzyme technology and cancer therapy: Cleave and let die. Molecular Cancer Therapeutics , 7 (2). pp. 243-251. ISSN 1535-7163
Dass, Crispin.R and Choong, P.F.M (2008) Chitosan-mediated orally delivered nucleic acids: A gutful of gene therapy. Journal of Drug Targeting, 16 (4). pp. 257-261. ISSN 1061-186X
Dass, Crispin.R and Choong, P.F.M (2008) uPAR mediated anticancer activity of PEDF. Cancer Biology and Therapy, 7 (8). pp. 1262-1270. ISSN 1538-4047
Dass, Crispin.R and Choong, P.F.M (2008) The use of chitosan formulations in cancer therapy. Journal of Microencapsulation, 25 (4). pp. 275-279. ISSN 0265-2048
Dass, Crispin.R, Friedhuber, A, Khachigian, L, Dunstan, D and Choong, P.F.M (2008) Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. Journal of Microencapsulation, 25 (6). pp. 421-425. ISSN 0265-2048
Dudhania, Anitha R and Kosarajua, Shantha L (2010) Bioadhesive chitosan nanoparticles: Preparation and characterization. Carbohydrate Polymers, 81 (2). pp. 243-251. ISSN 0144-8617
E
Elahy, Mina and Dass, Crispin R (2011) Dz13: c-Jun downregulation and tumour cell death. Chemical Biology and Drug Design, 78 (6). pp. 909-912. ISSN 1747-0277
H
Hallam, Karen, Olver, J, Begg, D and Norman, T (2008) An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. Human Psychopharmacology: Clinical and Experimental, 23 (2). pp. 129-137. ISSN 0885-6222
J
Jobst, E, Enriori, P, Sinnayah, P and Cowley, M (2006) Hypothalamic regulatory pathways and potential obesity treatment targets. Endocrine, 29 (1). pp. 33-48. ISSN 0969-711X
K
Kelly, Anne-Maree, Kerr, Debra and Dietze, Paul (2009) Intranasal Naloxone for Treatment of Opioid Overdose. In: Opioid Receptors and Antagonists : From Bench to Clinic. Humana Press, New York, USA, pp. 729-739. ISBN 9781588298812
Kelly, Anne-Maree, Kerr, Debra, Dietze, Paul, Patrick, Ian, Walker, Tony and Koutsogiannis, Zeff (2005) Randomised Trial of Intranasal Versus Intramuscular Naloxone in Prehospital Treatment for Suspected Opioid Overdose. Medical Journal of Australia, 182 (1). pp. 24-27. ISSN 0025-729X
Kostraby, Margaret Mary (1999) The yeast mediated synthesis of the l-ephedrine precursor, l-phenylacetylcarbinol, in an organic solvent. PhD thesis thesis, Victoria University of Technology.
L
Lichtenberg, Frank (2010) Pharmaceutical innovation and mortality in the United States, 1960–2000. A commentary on Schnittker and Karandinos. Social Science & Medicine, 70 (7). pp. 969-971. ISSN 0277-9536
Lichtenberg, Frank R (2009) Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003. Health Economics, 18 (5). pp. 519-534. ISSN 1057-9230
Lichtenberg, Frank R (2009) Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature. Expert Review of Pharmacoeconomics and Outcomes Research , 9 (6). pp. 499-504. ISSN 1473-7167
Lichtenberg, Frank R (2009) The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978–2004. Economics of Innovation and New Technology, 18 (5). pp. 407-428. ISSN 1043-8599 (print), 1476-8364 (online)
Lichtenberg, Frank R, Grootendorst, Paul, Van Audenrode, Marc, Latremouille-Viau, Dominick and Lefebvre, Patrick (2009) The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec’s Provincial Health Plan Data. Value in Health, 12 (6). pp. 847-856. ISSN 1098-3015
Lim, Crystale Siew-Ying, Wong, Won-Fen, Rosli, Rozita, Ng, Kee-Peng, Seow, Heng and Chong, Pei-Pei (2009) 2-dodecanol (decyl methyl carbinol) inhibits hyphal formation and SIR2 expression in C. albicans. Journal of Basic Microbiology, 49 (6). pp. 579-583. ISSN 0233-111X, 15214028(online)
M
Malhotra, Prabodh (2008) The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India. Indian Journal of Medical Ethics, 5 (2). pp. 61-65. ISSN 0019-5359
Merl, Wolfgang, Koutsogiannis, Zeff, Kerr, Debra and Kelly, Anne-Maree (2007) How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning? Hong Kong Journal of Emergency Medicine, 14. pp. 198-203. ISSN 1024-9079
Messinis, George (2011) Triadic Citations, Country Biases and Patent Value: The Case of Pharmaceuticals. Scientometrics, 89 (3). pp. 818-833. ISSN 0138-9130
Miller, Peter G, Johnston, Jennifer, Dunn, Matthew, Fry, Craig L and Degenhardt, Louisa (2010) Comparing probability and non-probability sampling methods in ecstasy research: Implications for the Internet as a research tool. Substance Use and Misuse, 45 (3). pp. 437-450. ISSN 1082-6084
P
Phung, M. W and Dass, Crispin.R (2006) In-vitro and in-vivo assays for angiogenesis-modulating drug discovery and development. Journal of Pharmacy and Pharmacology, 58 (2). pp. 153-160. ISSN 0022-3573
S
Sampat, Bhaven N and Lichtenberg, Frank R (2011) What are the Respective Roles of the Public and Private Sectors in Pharmaceutical Innovation? Health Affairs, 30 (2). pp. 332-339. ISSN 0278-2715
T
Ta, H, Larson, I, Dass, Crispin.R, Dunstan, D and Han, H (2009) Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system. International Journal of Pharmaceutics, 371 (1-2). pp. 134-141. ISSN 0378-5173
V
Van Moorst, Mallory and Dass, Crispin R (2011) Methods for co-culturing tumour and endothelial cells: Systems and their applications. Journal of Pharmacy and Pharmacology, 63 (12). pp. 1513-1521. ISSN 0022-3573
Vatjanapukka, Verawoot (2004) Consumer attitudes towards medical information : an exploratory study of direct-to-consumer prescription drug advertising in Australia. Other Degree thesis thesis, Victoria University of Technology.

